M Holdings Securities Inc. Acquires 5,394 Shares of Cardinal Health, Inc. $CAH

M Holdings Securities Inc. acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 5,394 shares of the company’s stock, valued at approximately $1,235,000.

Several other large investors also recently bought and sold shares of CAH. Pinnacle Associates Ltd. lifted its stake in Cardinal Health by 2.9% during the 3rd quarter. Pinnacle Associates Ltd. now owns 1,404 shares of the company’s stock valued at $312,000 after acquiring an additional 39 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Cardinal Health by 1.4% during the 3rd quarter. Parallel Advisors LLC now owns 3,004 shares of the company’s stock valued at $668,000 after acquiring an additional 41 shares during the last quarter. LWM Advisors Inc. grew its stake in shares of Cardinal Health by 4.4% in the second quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock worth $244,000 after acquiring an additional 43 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Cardinal Health by 2.5% in the second quarter. Parkside Financial Bank & Trust now owns 1,793 shares of the company’s stock worth $426,000 after acquiring an additional 43 shares during the period. Finally, Raleigh Capital Management Inc. raised its holdings in shares of Cardinal Health by 2.9% during the third quarter. Raleigh Capital Management Inc. now owns 1,541 shares of the company’s stock valued at $343,000 after purchasing an additional 43 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Cardinal Health

In related news, insider Jessica L. Mayer sold 29,436 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company’s stock, valued at approximately $7,812,220.44. This trade represents a 47.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle D. Greene sold 11,650 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the transaction, the insider owned 10,330 shares in the company, valued at $2,434,987.60. This trade represents a 53.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 210,271 shares of company stock worth $49,626,657. Insiders own 0.12% of the company’s stock.

Cardinal Health Trading Up 0.8%

CAH opened at $273.95 on Tuesday. The company has a market cap of $63.44 billion, a price-to-earnings ratio of 35.44, a PEG ratio of 1.57 and a beta of 0.53. The company’s 50 day moving average is $241.24 and its 200 day moving average is $223.87. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $67.51 billion during the quarter, compared to analysts’ expectations of $66.67 billion. During the same period in the prior year, the company earned $2.55 earnings per share. The firm’s revenue was up 5.5% on a year-over-year basis. As a group, analysts predict that Cardinal Health, Inc. will post 12.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. UBS Group lifted their target price on shares of Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research report on Friday, October 16th. Mizuho set a $290.00 price target on Cardinal Health in a report on Thursday. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 25th. TD Cowen raised their price target on Cardinal Health from $280.00 to $304.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Weiss Ratings raised Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Thursday, October 8th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $274.00.

Cardinal Health Profile

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations.

Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.